Fetal Programming

Sources consulted:

Barouki, R., Gluckman, P., Grandjean, P., Hanson, M., & Heindel, J. (2012). Developmental origins of non-communicable disease: Implications for research and public health. Environmental Health, 11, 42. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384466/pdf/1476-069X-11-42.pdf

Maritz, G., & Harding, R. (2011). Life-long programming implications of exposure to tobacco smoking and nicotine before and soon after birth: Evidence for altered lung development. International Journal of Environmental Research and Public Health, 8(3), 875-98. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083675/pdf/ijerph-08-00875.pdf

Moisiadis, V. G., & Matthews, S. G. (2014a). Glucocorticoids and fetal programming part 1: Outcomes. Nature Reviews. Endocrinology, 10(7), 391-402. http://doi.org/10.1038/nrendo.2014.73

Puddu, M., Fanos, V., Podda, F., & Zaffanello, M. (2009). The kidney from prenatal to adult life: Perinatal programming and reduction of number of nephrons during development. American Journal of Nephrology, 30(2), 162-170. https://doi.org/10.1159/000211324

Remacle, C., Dumortier, O., Bol, V., Goosse, K., Romanus, P., Theys, N., Bouckenooghe, T., & Reusens, B. (2007). Intrauterine programming of the endocrine pancreas. Diabetes, Obesity and Metabolism, 9, 196-209. http://doi.org/10.1111/j.1463-1326.2007.00790.x

Reynolds, R. M. (2013). Glucocorticoid excess and the developmental origins of disease: Two decades of testing the hypothesis – 2012 Curt Richter Award Winner. Psychoneuroendocrinology, 38(1), 1-11.http://doi.org/10.1016/j.psyneuen.2012.08.012

Sookoian, S., Gianotti, T. F., Burgueno, A. L., & Pirola, C. J. (2013). Fetal metabolic programming and epigenetic modificiations: A systems biology approach. Pediatric Research, 73(4), 531-542. https://www.nature.com/articles/pr20132.pdf